HEADINVEST, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
HEADINVEST, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,838,179
-2.0%
18,1030.0%0.40%
-1.2%
Q2 2023$1,875,290
+9.3%
18,103
-2.9%
0.40%
+7.4%
Q1 2023$1,715,432
+0.7%
18,646
-0.7%
0.38%
-1.3%
Q4 2022$1,702,724
+18.1%
18,769
-1.0%
0.38%
+10.4%
Q3 2022$1,442,000
-11.6%
18,965
-1.8%
0.34%
-5.0%
Q2 2022$1,632,000
+2.3%
19,310
+6.2%
0.36%
+19.0%
Q1 2022$1,595,000
+1.5%
18,175
+1.2%
0.30%
+9.3%
Q4 2021$1,571,000
+27.8%
17,966
+19.6%
0.28%
+19.7%
Q3 2021$1,229,000
-10.7%
15,026
-0.4%
0.23%
-11.1%
Q2 2021$1,376,000
+8.2%
15,089
+1.3%
0.26%
+0.8%
Q1 2021$1,272,000
-8.4%
14,890
+1.3%
0.26%
-11.9%
Q4 2020$1,388,000
+24.2%
14,696
+14.3%
0.30%
-8.7%
Q3 2020$1,118,000
-1.1%
12,852
-0.8%
0.32%
-9.3%
Q2 2020$1,131,000
+5.9%
12,952
-0.0%
0.36%
-11.0%
Q1 2020$1,068,000
-11.5%
12,958
+1.6%
0.40%
+15.3%
Q4 2019$1,207,000
+7.7%
12,752
-1.2%
0.35%
+2.1%
Q3 2019$1,121,000
-10.8%
12,902
-6.2%
0.34%
-4.5%
Q2 2019$1,257,000
-5.0%
13,7620.0%0.36%
-4.0%
Q1 2019$1,323,000
-46.4%
13,762
-52.1%
0.37%
-5.1%
Q4 2018$2,467,000
+99.3%
28,746
+100.0%
0.39%
+9.8%
Q3 2018$1,238,000
+16.2%
14,373
+2.0%
0.36%
+9.5%
Q2 2018$1,065,000
-5.9%
14,098
+0.7%
0.32%
-10.5%
Q1 2018$1,132,000
-5.7%
14,005
-2.1%
0.36%
-1.9%
Q4 2017$1,201,000
+0.5%
14,305
-1.2%
0.37%
-1.1%
Q3 2017$1,195,000
-3.6%
14,475
-2.5%
0.37%
-8.3%
Q2 2017$1,239,000
+10.2%
14,845
-1.9%
0.41%
+7.9%
Q1 2017$1,124,000
+4.1%
15,130
+2.0%
0.38%
-6.0%
Q4 2016$1,080,000
+43.2%
14,830
+52.9%
0.40%
+50.6%
Q3 2016$754,000
+7.0%
9,700
+13.5%
0.27%0.0%
Q2 2016$705,000
+13.9%
8,5500.0%0.27%
+10.3%
Q1 2016$619,000
-12.8%
8,550
+3.6%
0.24%
-16.0%
Q4 2015$710,000
-18.6%
8,250
-13.1%
0.29%
-17.7%
Q3 2015$872,000
-6.5%
9,4900.0%0.35%
+1.4%
Q2 2015$933,000
-6.9%
9,490
-6.6%
0.34%
-4.2%
Q1 2015$1,002,000
+14.0%
10,160
+7.1%
0.36%
+2.6%
Q4 2014$879,000
+12.8%
9,490
+13.0%
0.35%
+12.9%
Q3 2014$779,000
+49.8%
8,400
+46.3%
0.31%
+48.1%
Q2 2014$520,000
+6.6%
5,7400.0%0.21%0.0%
Q1 2014$488,000
+15.9%
5,740
+9.5%
0.21%
+18.6%
Q4 2013$421,000
+2.7%
5,240
-1.9%
0.18%
-1.1%
Q3 2013$410,000
+8.5%
5,3400.0%0.18%
+7.8%
Q2 2013$378,0005,3400.17%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders